Showing results (281-290 of 352) with videos related to
Sort By:
Pageof 36
Dermatology Online Journal|July 29, 2026
The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domainsDanny Zakria, Milaan Shah, Angela Rosenberg, et al.Dermatology and Therapy|February 15, 2022
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17April W Armstrong, Andrew Blauvelt, Ulrich Mrowietz, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Item-level psychometric properties for a new patient-reported psoriasis symptom diaryBruce E Strober, Judit Nyirady, Usha G Mallya, et al.Journal of the American Academy of Dermatology|August 29, 2024
A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvementMark Lebwohl, Michael Bukhalo, Linda Stein Gold, et al.Dermatology Online Journal|July 29, 2026
A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panelMilaan Shah, Lauren DeBusk, M Hunter Bohman, et al.Journal of the American Academy of Dermatology|July 17, 2017
Herpes zoster in psoriasis patients treated with tofacitinibKevin L Winthrop, Mark Lebwohl, Arnon D Cohen, et al.The British Journal of Dermatology|February 8, 2023
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trialsGeorgios Kokolakis, Richard B Warren, Bruce Strober, et al.Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.Journal of the American Academy of Dermatology|March 29, 2003
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.Journal of the American Academy of Dermatology|February 28, 2002
Cost of atopic dermatitis and eczema in the United StatesCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.Pageof 36